Voltage-gated sodium channels are critical determinants of neuronal excitability. Experimental and clinical evidence clearly demonstrates that sodium channels and changes in the properties of these channels can play crucial roles in chronic pain and other neurological disorders. However, at least six different sodium channel isoforms are expressed in peripheral sensory neurons, and investigating the role of specific voltage- gated sodium channel isoforms in normal and abnormal electrical activity of sensory neurons has been hindered by the lack of isoform specific neuronal sodium channel blockers. The goal of this R21 grant proposal is to develop selective sodium channel blockers based on biological peptide toxins that can be used to investigate the role(s) of specific sodium channel isoforms in disorders of excitability such as pain. Biological toxins have been invaluable in researching the role of ion channels in disease and some toxins that target ion channels are important therapeutics. Our preliminary data show that a toxin in the venom from the tarantula Ornithoctonus huwena inhibits TTX-sensitive neuronal sodium channels but not TTX- resistant neuronal sodium channels, cardiac sodium channels or skeletal muscle sodium channels. Furthermore, these data indicate that this toxin is more potent at blocking Nav1.6 and Nav1.7 TTX-sensitive channels than Nav1.1, 1.2 and 1.3 TTX-sensitive sodium channels. This toxin is an excellent candidate molecule on which to base the development of isoform specific sensory neuronal sodium channel blockers. This project has two related specific aims: 1. Identify the isoform specific determinants of sodium channel sensitivity to tarantula toxins. 2. Develop toxin analogs with enhanced selectivity for specific voltage-gated sodium channel isoforms. Whole-cell patch-clamp electrophysiology, mutagenesis of recombinant ion channels and peptide synthesis will be used to investigate toxin-channel interactions. The experiments proposed here will determine the feasibility of using tarantula toxins as the basis for developing novel tools to determine the roles of specific sodium channels in normal and abnormal physiology of sensory neurons. The long-term goal of this research is to develop sodium channel blockers that are useful as novel therapeutics for the treatment of neurological disorders of hyperexcitability such as chronic pain. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21NS054642-02
Application #
7346915
Study Section
Somatosensory and Chemosensory Systems Study Section (SCS)
Program Officer
Silberberg, Shai D
Project Start
2007-02-01
Project End
2010-01-31
Budget Start
2008-02-01
Budget End
2010-01-31
Support Year
2
Fiscal Year
2008
Total Cost
$168,000
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Pharmacology
Type
Schools of Medicine
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Thapa, Parashar; Cabalteja, Chino C; Philips 3rd, Edwin E et al. (2016) t-boc synthesis of huwentoxin-i through native chemical ligation incorporating a trifluoromethanesulfonic acid cleavage strategy. Biopolymers 106:737-45
Xiao, Yucheng; Jackson 2nd, James O; Liang, Songping et al. (2011) Common molecular determinants of tarantula huwentoxin-IV inhibition of Na+ channel voltage sensors in domains II and IV. J Biol Chem 286:27301-10
Xiao, Yucheng; Blumenthal, Kenneth; Jackson 2nd, James O et al. (2010) The tarantula toxins ProTx-II and huwentoxin-IV differentially interact with human Nav1.7 voltage sensors to inhibit channel activation and inactivation. Mol Pharmacol 78:1124-34
Dib-Hajj, Sulayman D; Binshtok, Alexander M; Cummins, Theodore R et al. (2009) Voltage-gated sodium channels in pain states: role in pathophysiology and targets for treatment. Brain Res Rev 60:65-83
Xiao, Yucheng; Bingham, Jon-Paul; Zhu, Weiguo et al. (2008) Tarantula huwentoxin-IV inhibits neuronal sodium channels by binding to receptor site 4 and trapping the domain ii voltage sensor in the closed configuration. J Biol Chem 283:27300-13